Results 121 to 130 of about 66,426 (248)

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Palace of Manufactures

open access: yes, 1904
Long view of Palace of Manufactures, with canal and canal boats in ...
Louisiana Purchase Exposition Co. (Saint Louis, Mo.)
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

A letter to the citizens of Pennsylvania, on the necessity of promoting agriculture, manufactures, and the useful arts. By George Logan, M.D.

open access: yes
28 p. ; 20 cm. (8vo)"The Constitution of the Lancaster County Society, for Promoting of Agriculture, Manufactures, and the Useful Arts."--p. [13]-21."An act for the promotion of agriculture, manufactures, and the useful arts."--p. 22-28; "...
Lancaster County Society, for Promoting of Agriculture, Manufactures and the Useful Arts.   +1 more
core  

1958 Census of Manufactures. Arizona.

open access: yes, 2019
The 1958 Census of Manufactures is the twenty-sixth such census of the United States. The 1958 Census of Manufactures covers all establishments primarily engaged in manufacturing as defined in the revised Standard Industrial Classification Manual, issued
United States Census Bureau; United States Department of Commerce
core  

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

1963 Census of Manufactures. Arizona.

open access: yes, 2019
The 1963 Census of Manufactures is the twenty-seventh such census of the United States. The 1963 Census of Manufactures covers all establishments primarily engaged in manufacturing as defined in the 1957 edition of the Standard Industrial Classification ...
United States Census Bureau; United States Department of Commerce
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy